Jim Cramer Blog

Discuss Hot Stocks, Jim Cramer, Mad Money,the Stock and Option Markets, and the economy on Jim Cramer Blog.

Monday, January 21, 2008

Hot Stocks to Watch Tuesday

Here are 7 stocks for traders for Tuesday from TradingMarkets.com:
Bank of America (NYSE:BAC - News) reports earnings on Tuesday morning, with traders looking for $0.18 EPS. BAC's PowerRating (for Traders) is 5.
DuPont (NYSE:DD - News) is looking to report $0.49 EPS on Tuesday before the market opens. DD's PowerRating (for Traders) is 5.
Analyst will be watching for Fastenal (NasdaqGS:FAST - News) to announce $0.36 EPS on Tuesday before the bell. FAST's PowerRating (for Traders) is 6.
When Johnson & Johnson (NYSE:JNJ - News) announces quarterly results on Tuesday morning, watch for $0.86 EPS. JNJ's PowerRating (for Traders) is 6.
Suncor Energy (NYSE:SU - News) is poised to announce $1.51 EPS early Tuesday morning. SU's PowerRating (for Traders) is 6.
UnitedHealth (NYSE:UNH - News) should report $0.92 EPS on Tuesday morning. UNH's PowerRating (for Traders) is 6.
Wachovia (NYSE:WB - News) is expected to report $0.33 EPS early Tuesday. WB's PowerRating (for Traders) is 6.

Labels: , , , , , , ,

Monday, November 19, 2007

Jim Cramer's Mad Money Stock Recap Nov. 16th

On Friday Cramer bagan by talking about a recommendation he made on Thursday in the Lightning Round that he wants to correct. He had said that St. Jude Medical (STJ) was a sell, and after giving it some thought, he realized that it should be a buy. His reasons were that Medtronic (MDT) had a recall in a market where these two companies are the only players, health care stocks are good defensive plays, and it is trading at just over 1X its growth rate.
Then Cramer went to the phonelines. The first caller asked about Johnson & Johnson (JNJ), and Cramer said that it is a safe play in a slowing economy, plus Warren Buffet is buying shares. Second caller asked about Humana (HUM), and Cramer said that he doesn't know why the analysts don't like the stock, and that it is a cheap stock. He also said that he likes UnitedHealth (UNH) better, partially because Warren Buffet is buying this as well. Another caller asked about Hansen Medical (HNSN), and Cramer said that he thinks it has run its course and he doesn't want anything to do with it. The last caller asked about Beijing Medical (BJGP), and Cramer said that he won't recommend this Chinese stock since they are so risky.
Cramer came back and talked to (CSX) CEO Michael Ward who talked about their stock buyback, upcoming earnings, and why a hedge fund has been asking for a change in leadership. Cramer concluded that this stock is a buy.
In Cramer's "Game Plan" for next week, he said that he won't be recommending any individual stocks because the big investors are unsure right now, so they are unpredictable. Cramer said that Wells Fargo (WFC) gave a very negative report on the housing market and they are one of the best banking stocks out there, so the bad banking stocks must be really suffering. He said to get out of Countrywide (CFC), Washington Mutual (WM), Downey Financial (DSL), E*Trade (ETFC), Standard Pacific (SPF), Pulte Homes (PHM), Centex (CTX), and Beazer (BZH), and buy defensive stocks like Coca-Cola (KO), Altria (MO), Colgate (CL), Clorox (CLX), Avon (AVP), and Medco Health (MHS). Cramer said that things have gotten much worse for the economy recently, and the Fed can't let the economy fall apart, so they will have to take action soon.
Cramer went over his mining picks that have been doing well: BHP Billiton (BHP), C.V.R.D. (RIO), and Freeport McMoran (FCX), and then talked with the CEO of one that hasn't: Lundin Mining (LMC). It is down since they didn't have a very good quarter and he wants to know whether it is time to give up on the stock or buy more. The CEO was optimistic, but Cramer said that he wants you to wait until they report another quarter before buying more.
Lastly, Cramer did a review of the week and ended the show.

Labels: , , , , , , , , , , ,

Thursday, September 13, 2007

Stock Options to Watch Today

Here are 7 options to watch for Today.
Most Underpriced Calls: These are the most under priced calls of all stocks in our database. While the Equities Explosion List finds groups of calls for individual equities that are under priced, this list finds the most under priced individual calls. Thus, the options listed here will tend to be more severely under priced.
MasterCard Oct 160 Calls (NYSE:MA - News). MA's PowerRating (for Traders) is 4.
Most Underpriced Puts: These are the most under priced puts of all stocks in our database. While the Equities Explosion List finds groups of puts for individual equities that are under priced, this list finds the most under priced individual puts. Thus, the options listed here will tend to be more severely under priced.
UnitedHealth Group Sep 50 Puts (NYSE:UNH - News). UNH's PowerRating (for Traders) is 4.
Most Overpriced Calls: These are the most overpriced calls of all stocks in our database. While the Equities Implosion List finds groups of calls for individual equities that are overpriced, this list finds the most overpriced individual calls. Thus, the options listed here will tend to be more severely overpriced.
Whole Foods Market Nov 45 Calls (NYSE:WFMI - News). WFMI's PowerRating (for Traders) is 5.
Most Overpriced Puts: These are the most overpriced puts of all stocks in our database. While the Equities Implosion List finds groups of puts for individual equities that are overpriced, this list finds the most overpriced individual puts. Thus, the options listed here will tend to be more severely overpriced.
Wynn Resorts Oct 120 Puts (NYSE:WYNN - News). WYNN's PowerRating (for Traders) is 4.
Stocks with Abnormal Call Volume: These are stocks which showed unusual call option volume not easily explained by arbitrage operations. The appearance of a stock on the Call Volume Alerts list suggests a possible takeover, extraordinarily good earnings report, or other news which may favorably affect the stock.
WebMD (NasdaqGS:WBMD - News). WBMD's PowerRating (for Traders) is 5.
Stocks with Abnormal Put Volume: These are stocks which showed unusual put option volume not easily explained by arbitrage operations. The appearance of a stock on the Put Volume Alerts list suggests an extraordinarily negative earnings report, or other news which may negatively affect the stock.
None Today
Abnormal Put/Call $ Volume: These stocks have the highest dollar put volume in relation to their call volume. These high ratios are indicative of extreme bearish sentiment in the underlying stock.
QUALCOMM (NasdaqGS:QCOM - News). QCOM's PowerRating (for Traders) is 4.

Labels: , , , , ,

Monday, August 06, 2007

Jim Cramer's Mad Money Lightning Round Aug. 3rd

Bullish calls:
Raytheon (NYSE: RTN - News): 'Raytheon's probably the cheapest.'General Dynamics (GDNorthrop Grumman (NYSE: NOC - News)Lockheed Martin (NYSE: LMT - News)Frontline (NYSE: FRO - News):'Yours is a winner. Frontline is a buy. I see the stock went down today, but, you know, a lot of stocks went down today. That's a good one.'UnitedHealth (NYSE: UNH - News): 'Understand, I've owned this stock for a couple of years for my charitable trust. This is precisely the kind of stock that does well on a slowdown. ... I want to buy the stock.'Norfolk Southern (NYSE: NSC - News): 'Every railroad stock has been killed. ... All of them are owned by very big hedge funds. ... People say to themselves, 'I guess all the hedge funds are getting killed.' That is not true. ... I still like the stock.'Trinity Industries (NYSE: TRN - News): 'When this mortgage mess clears up, I think Trinity comes back. I think that's the kind of stock you buy. ... I'm not backing away."'Nastech Pharmaceutical (NasdaqGM: NSTK - News): 'I would prefer, if you want to speculate, that you speculate with Nastech Pharmaceutical.'American Standard (NYSE: ASD - News): 'I frankly don't know why the market hates it so much. ... I'm stickin' by. It's painful, but I'm stickin' by it.'LKQ (NasdaqGS: LKQX - News): 'I like your company. I would stick with it.'Yamana Gold (NYSE: AUY - News): 'I'll stick with Yamana.'
Bearish calls:
Boston Scientific (NYSE: BSX - News): 'They canceled an IPO. I don't like the balance sheet. This is not my favorite company in the group. Even at $13, I'm going to reiterate that I can't get behind the medical company Boston Scientific.'Spartan Motors (NasdaqGS: SPAR - News)Jones Soda (NasdaqCM: JSDA): 'They missed the quarter. You cannot miss the quarter and be a high-multiple stock. Not only did they miss the quarter -- they missed the last quarter. ... I cannot pull the trigger. ... Jones is in the penalty box.'Limited Brands (NYSE: LTD - News): 'Here's a company that's doing absolutely everything right, but no one cares. My take is this: The Limited is too cheap, but I can't think of a catalyst to turn this stock around.'St. Joe (NYSE: JOE - News): 'I cannot be in the stock. It's just not the place to be.'WCI Communities (NYSE: WCI - News)SuperGen (NasdaqGM: SUPG - News)Coeur d'Alene Mines (NYSE: CDE - News): 'I have never been a fan of Coeur d'Alene. They always issue a lot of stock. They never seem to go anywhere.'
Published By SeekingAlpha

Labels: , , , , , , , , , , , , , , , , , , ,

Friday, April 20, 2007

Jim Cramer's Wall Street Confidential April 19th

Altria (NYSE: MO), Coca-Cola (NYSE: KO), UnitedHealth (NYSE: UNH), Humana (NYSE: HUM), Nokia (NYSE: NOK), Motorola (NYSE: MOT)
Cramer lamented that it is "too hard" to invest during earnings season, and had been faced with several disappointments, including Altria's "crummy" quarter which it tried to explain away by citing problems in Germany and Japan; "You buy the stock off the dividend and off the fact that its valuation is so low. But there's no masking a crummy quarter when you've got one," he said, and commented that KO was the winner in this space. Cramer was "flabbergasted" that UNH "totally missed execution" and while it can make money because it has a low mulitple, UNH is no longer a good company, he said. Although UNH blamed high medical costs, Cramer noted Humana is dealing with the same problem and yet is going up. Nokia is doing well only because MOT is doing badly, and while Nokia's quarter wasn't great, Cramer predicts it will go from $24 to $30. He added: "One of the most disheartening things about trying to invest in this environment is that Nokia looked bad, but you had to buy it, and Motorola tried to look good, but you had to sell it."
Published By SeekingAlpha

Labels: , , , , , , ,

Monday, March 12, 2007

Stock Market Wrapup Mar. 12

Sliding oil prices and a spate of M&A deals spurred investors to resume buying stocks. In doing so, they looked past the struggle that one of the nation's leading subprime lenders faces in a bid to survive. After a lackluster start to the week, buying picked up in the mid-afternoon as the major stock averages pushed sharply higher before easing somewhat in the final 30 minutes of trading. The 10-year Treasury note also attracted buyers, which cut the yield -4 basis points to 4.55%. Crude oil futures dipped near $59 a barrel.
Early in the day, the market was focused on the travails of New Century Financial (NYSE: NEW - News), which appears to be teetering on the brink of insolvency. The company disclosed in a filing with the Securities and Exchange Commission that all of its lenders have either cut financing or will cease to finance New Century's short-term borrowings. New Century said last Thursday it would no longer accept new loan applications due to liquidity problems. The company hinted it does not have the funds to meet current obligations, which may exceed $8 billion. Subscribers can read further analysis on the fallout from this latest development in today's issue.
Merger activity helped shake off the cloud created by New Century's woes. Ford Motor (NYSE: F - News) took a step toward funding its own recovery plan by announcing it has sold its Aston Martin unit to a consortium of investors for $848 million. The U.K.-based unit is best known for the exotic, pricey sports cars used in the James Bond movie series. The car now retails for between $110,000 and $270,000 each.
Schering-Plough (NYSE: SGP - News), meanwhile, announced it plans to buy the pharmaceuticals division of Akzo Nobel (Nasdaq: AKZOY - News) for $14.5 billion in cash. U.S.-traded shares of Akzo, a Dutch company, jumped 16% on the news. The deal will given Schering the Akzo Organon Biosciences unit, which makes a range of fertility, birth control, and women's health products. That addition should lessen Schering's dependence on its Vytorin and Zetia cholesterol-lowering drugs. Organon also has a treatment for schizophrenia and bipolar disorder in late-stage development, but Pfizer (NYSE: PFE - News), its partner in the development of the drug asenapine, dropped out after the treatment achieved mixed results in clinical trials.
In the health insurance sector, UnitedHealth Group (NYSE: UNH - News) agreed to buy Sierra Health Services (NYSE: SIE - News) for about $2.6 billion in cash. Sierra services about 310,000 employer-sponsored health plan members in Nevada and another 320,000 members enrolled in senior and government programs nationwide. UnitedHealth offered $43.50 a share for Sierra, or roughly a 21% premium over Friday's close. Sierra added 16% today. Separately, Express Scripts (Nasdaq: ESRX - News) ended 5% higher on the day after announcing it would not raise its bid for rival Caremark Rx (NYSE: CMX - News). Express Scripts has been battling drug-store retailer CVS (NYSE: CVS - News) to acquire Caremark. Both Caremark and CVS ended down -2%.
In the final major deal of the day, the management of discount retailer Dollar General (NYSE: DG - News) agreed to a $6.9 billion buyout bid from Kohlberg Kravis Roberts. KKR offered $22 a share, a 31% premium over Friday's close, for the operator of more than 8,200 discount stores nationwide. Dollar General jumped 26% higher on the news.
By the BullMarket.com Staff

Labels: , , , , , , , , , ,

Stocks Stable on Subprime News

Stocks showed little movement Monday as further cracks appeared in the subprime lending sector, stirring concerns that a blowup among companies making loans to consumers with poor credit will spill over into other industries.
A warning from New Century Financial Corp. early Monday about its financial woes overshadowed merger news, which often gives a boost to enthusiasm on Wall Street.
The renewed concerns about subprime lenders follow a relatively successful week on Wall Street. Stocks etched out gains last week U.S. and overseas markets managed to regain some sense of stability following a sharp pullback that began Feb. 27. Even amid the gains seen last week, however, concerns about subprime lenders weighed on investors.
"We've had fairly flat trading given the continuing meltdown in New Century," said Frederic Dickson, market strategist and director of retail research at D.A. Davidson & Co. "The market appears to have handled this latest piece of news in a fairly decent and orderly way, almost as if had anticipated it happening at the end of last week."
In late morning trading, the Dow Jones industrial average fell 9.69, or 0.08 percent, to 12,266.63.
Broader stock indicators slipped. The Standard & Poor's 500 index fell 3.44, or 0.25 percent, to 1,399.41, and the Nasdaq composite index fell 0.80, or 0.03 percent, to 2,386.75.
Bonds rose amid the concerns about subprime lenders; the yield on the benchmark 10-year Treasury note falling to 4.54 percent from 4.59 percent late Friday. The dollar was mixed against other major currencies, while gold prices were little changed.
Light, sweet crude fell $1.17 to $58.88 per barrel on the New York Mercantile Exchange.
In corporate news, New Century warned in a filing with the Securities and Exchange Commission that all its lenders had cut off short-term funding or announced plans to do so after the subprime mortgage lender wasn't able to make payments. New Century, which relies on short-term borrowings to finance mortgage loan originations and purchases, said it would need about $8.4 billion should it be forced to repurchase all outstanding mortgage loans. The company said it doesn't have sufficient liquidity to meet its obligations for repurchasing mortgages.
Trading in New Century shares remained halted with news pending, as it had been before the opening bell.
Other subprime lenders fell sharply. Fremont General fell 86 cents, or 10.7 percent, to $7.17, while Novastar Financial Inc. fell 67 cents, or 12.8 percent, to $4.57.
Investors have grown uneasy about the subprime market amid fresh concerns about the ability of some homeowners with spotty credit to continue to make mortgage payments. Many of the mortgages came with low teaser rates and a cooling housing market has made it more difficult for people to extract cash from equity in their homes by refinancing.
Amid the din over subprime lenders, buyout news offered some support for stocks. Word that private-equity company Kohlberg Kravis Roberts & Co. struck a deal to acquire Dollar General Corp. for about $6.87 billion sent the discount retailer sharply higher. Dollar General jumped $4.38, or 26.1 percent, to $21.16 -- well past the stock's 52 week high of $18.32.
As often occurs when a company announces an acquisition, Schering-Plough Inc. fell 22 cents to $23.63 after agreeing to purchase the Organon BioSciences BV pharmaceuticals business of Akzo Nobel NV, the Dutch maker of chemicals and coatings, for $14.5 billion. Akzo rose $9.94, or 16.4 percent, to $70.75.
UnitedHealth Group Inc., the health insurer, announced plans to acquire health care services provider Sierra Health Services Inc. for about $2.6 billion. Sierra Health rose $5.66, or 15.8 percent, to $41.56, while UnitedHealth advanced 28 cents to $53.28.
Boeing Co., one of the 30 stocks that make up the Dow industrials, said Kuwait-based Alafco Aviation Lease and Finance Co. agreed to purchase 18 airplanes with a list value of $2.26 billion. The deal includes 12 787-8 Dreamliner airplanes and six 737-800s. Boeing rose 97 cents to $90.48.
Procter & Gamble Co., the consumer products company, said it struck a deal to sell its Western European tissue and towel business to SCA, which makes paper and other products, for about $671.9 million. P&G, also a Dow component, advanced 11cents to $62.27.
Declining issues outnumbered advancers by about 8 to 7 on the New York Stock Exchange, where volume came to 469.6 million shares.
The Russell 2000 index of smaller companies fell 1.29, or 0.16 percent, to 783.83.
Overseas, Japan's Nikkei stock average rose 0.75 percent, Hong Kong's Hang Seng index added 1.61 percent and the Shanghai Composite Index added 0.58 percent. In afternoon trading, Britain's FTSE 100 fell 0.29 percent, Germany's DAX index slipped 0.08 percent, and France's CAC-40 fell 1.02 percent.

Labels: , , , , , , ,

Wednesday, February 21, 2007

Jim Cramer's Mad Money Stock Recap Feb. 20

Jim Cramer, Mad Money, NTRI, MRT, DRI, LU, AMZN, Ebay, UNH
Rule #1: Resisting the Business Cycle, United Health Group (NYSE: UNH - News)
Cramer discussed more rules from his books: Jim Cramer's Real Money: Sane Investing in an Insane World, and Jim Cramer's Mad Money: Watch TV, Get Rich. His first rule deals with the business cycle which is largely controlled by the Federal Reserve's raising and cutting interest rates. When rates are reduced, the economy gets stronger, and investors should buy cyclicals such as "the dirty, smokestack stocks that make things like machinery, cars and minerals." When the Fed raises rates, the economy gets weaker, and it is time to get out of cyclical stocks and into companies that produce consumer staples, such as food and drugs. "You can't own cyclical stocks when the economy stinks, and you should stay away from the consumer staples when the economy's stronger," Cramer said, adding that this applies even if a company has strong fundamentals. He recalls his error of holding on to UNH when the economy picked up, and said that the selloff during the boom was a much bigger factor in the stock's decline than UNH's involvement in an options-backdating scandal.
Rule #2: "Analysts are never bullish enough on good stocks, and ... never bearish enough on bad stocks.": Ebay (NasdaqGS: EBAY), Amazon (NasdaqGS: AMZN) and Lucent (NYSE: LU - News)
The reason for the second rule is that analysts covering a stock are dealing with an entire sector for which they must find some stocks that are buys, sells and holds. "The Street will almost always treat a sector that's en fuego as being a lot less en fuego than it actually is," he said. Knowing this, investors can more easily spot which sectors are hot but underappreciated.He noted that this happened with oil stocks during certain times in the past few years when the sector was hot. Even the companies that were neglected or had a "sell" rating went up anyway. It can work the other way too, and Cramer thinks that analysts should have stayed bearish on eBay, Amazon and Lucent for a longer period of time.
Rule #3: Don't Be a Snob, Darden (NYSE: DRI - News), Ruth's Chris Steakhouse (NasdaqGS: RUTH), Morton's (NYSE: MRT - News)
Because analysts inhabit an upper-class bubble, Cramer says they often miss out on companies that make low-end or mid-grade products. While they can more easily relate to stocks such as RUTH and MRT, most analysts missed out on 50% of Darden's big move between January 2005 and March 2006 because they turned their noses up at Red Lobster and the Olive Garden.
Rule #4 : "Whenever a stock is being heavily shorted and heavily hyped at the same time, it's time to sell that stock," NutriSystem (NasdaqGS: NTRI)
Hype and a large short interest do not mix, but create a battleground where an investors should fear to tread, and Cramer commented, "You don't do something as risky as shorting a stock unless you're a well-educated investor who has done his or her homework on the thing." One can do research on a stock page on Yahoo or Google finance to see the percentage of shares that are shorted, and a large percentage of shorts indicates that there is a problem the bulls don't know about or do not want to face, as was the case with NTRI, which had problems with its distribution model. "So when all the analysts are having their lovefest with the stock, and you have an army of shorts sitting on the sidelines, you should see a red flag," Cramer said.
"Past performance is not indicative of future success."
Cramer warns viewers not to rely on past successes as a model for future investments, since "stocks have no memory and you could lose big." Investors should aim to make money, but not to feel "invincible" if they do and should avoid following the same patterns. Cramer recommended playing by the rules outlined in his books for successful investing.

Published By SeekingAlpha

Labels: , , , , , , , ,

Friday, February 16, 2007

Jim Cramer's Stop Trading Feb. 15

Jim Cramer, Jim Cramer's Stop Trading, DE, Q, NSC, CAT, SWY, UNP, CSX, UNH, AET, LLY, LH, SGP

Deere (NYSE: DE - News), Qwest (NYSE: Q - News), Norfolk Southern (NYSE: NSC - News), Caterpillar (NYSE: CAT - News), Safeway (NYSE: SWY - News), Union Pacific (NYSE: UNP - News) and CSX Corp (NYSE: CSX - News): Cramer listed DE, Q, NSC, CAT and SWY as underappreciated "buys", adding that he sees no reason why DE will stop at $113. He observes that rails are on a "gigantic tear," but notes that although NSC is "delivering its numbers" it is his least favorite railroad stock. He prefers UNP, says that rumors of its guiding down are "nonesense" and predicts that it will reach $125 from $103. He also likes CSX, which is raising its dividend and buying back stock. Concerning Safeway, Cramer likes its gift card business, which he says is worth around $7 billion.
Aetna (NYSE: AET - News), Eli Lilly (NYSE: LLY - News), United Health (NYSE: UNH - News), Laboratory Corp of America Holdings (NYSE: LH - News), Schering Plough (NYSE: SGP - News): Cramer comments that the entire healthcare sector is "exploding" because Warren Buffett took a stake in UNH, and LH reported strong numbers. He likes AET, but says "No" to big pharma, especially LLY. While Cramer is bullish on SGP, he would take a breather since it has gone from $17 to $24 "in a straight line."


Published By SeekingAlpha

Labels: , , , , , , , , , , , , ,

Monday, February 05, 2007

Bullmarket.com Closing Wrap Feb. 5

Stocks drifted throughout a generally quiet trading day and finally closed mixed. The Dow Jones Industrial Average posted a slim gain, but the broader market averages closed lower. The 10-year Treasury note started off the week by moving higher, while crude oil and natural gas prices continued to climb as cold weather gripped a large portion of the nation.
Private equity investments were once again behind some of the day's sharpest gains. Triad Hospitals (NYSE: TRI - News) surged 15% after announcing that it had agreed to be acquired by CCMP Capital Advisors and GS Capital Partners for approximately $4.7 billion, excluding debt. Investor Carl Icahn, meanwhile, offered $2.8 billion for auto parts maker Lear (NYSE: LEA - News). Investors bid up the stock 11% on news of the $36 a share offer, but one current shareholder told The Wall Street Journal that the offer was "ridiculously low." Fellow auto parts makers like Tenneco (NYSE: TEN - News) and ArvinMeritor (NYSE: ARM - News) also closed higher.
In other merger news, State Street (NYSE: STT - News) announced that it would acquire Investors Financial Services (Nasdaq: IFIN - News) for $4.5 billion in an all-stock deal. Investors Financial shot up 27% on the announcement, but investors frowned on State Street, knocking its shares down -6% in the belief that it was overpaying. The companies each provide a variety of advisory and back-office services to institutional investors.
Health insurer Humana (NYSE: HUM - News) reported that Q4 earnings more than doubled, driven by strength in its Medicare business. The company reported profits of $155 million, or 92 cents per share, compared to $62 million, or 37 cents a share, in the year-ago period. Humana also raised its 2007 outlook. It now expects to earn $4.00-4.20 a share, up from its previous estimate of $3.90-4.10 per share. The nation's largest health insurer, in contrast, slipped today after UnitedHealth Group (NYSE: UNH - News) cut its 2007 revenue forecast, citing slippage in its Medicare-related health plans.
Wal-Mart (NYSE: WMT - News) rose after the company announced on Saturday that expected January same-store sales exceeded its earlier conservative forecast. Wal-Mart said same-store sales rose 2.2% last month, topping its estimate for an increase of 1-2%. Wal-Mart also said that starting with February's results, it will release same-store sales figures on the first Thursday of the following months, putting it on the same schedule as the majority of U.S. retailers.
Nursing home operator Kindred Healthcare (NYSE: KND - News) rose 5% after it was upgraded to a "buy" from "hold" by Stifel Nicolaus. Argonaut Group (Nasdaq: AGII - News), which underwrites specialty insurance products, gained 5% after releasing earnings and being upgraded to a "outperform" by Friedman Billings Ramsey. Argonaut reported a profit of $31 million, or 92 cents per share, in Q4, up from $25 million, or 76 cents per share, in the year-earlier quarter.
By Bullmarket.com Staff

Labels: , , , , , , , , , ,

Tuesday, January 30, 2007

Jim Cramer's Mad Money Stock Recap Jan. 29

Fallen Angel: VF. Corp (NYSE: VFC - News)
Cramer discussed "fallen angels" or stocks which deserve to trade at a higher multiple, but are down because of the market's stupidity. Cramer appaluds VFC's move in selling its "horrible" intimate apparel business which had "razor-thin margins" in order to let its more successful businesses thrive. However, investors did not hear this good news and instead paid too much attention to the company's disappointment with its fourth quarter and consequently "threw it down the pit." The stock dropped 7%, but Cramer predicts that it will miss its quarter by a mere three cents, and it should return to where it was and go higher after it reports on February 6.
Bad Press for Amgen (NasdaqGS: AMGN)
Cramer's second fallen angel, Amgen, was the victim of a negative headline which alleged that its Aranesp drug was potentially fatal when the patients who died were not expected to recover, regardless of the medicine. Low guidance was another factor in the stock's slip, but Cramer says that AMGN historically is conservative with guidance and expects to see an upside surprise. In addition, he notes that the company has drugs for osteoperosis and colon cancer in the pipeline.

Oxford Blues: Quest Diagnostic (NYSE: DGX - News), United Health (NYSE: UNH - News)
Cramer's third fallen angel is DGX, which fell apparently on the news of its split with Oxford Health, but Cramer believes that this factor was already built into the price. Cramer would buy DGX now, since it reported a good quarter and is cheap because of its low guidance. Although DGX thinks it will lose UNH, since UNH owns Oxford, Cramer does not believe this will happen and suspects DGX of low-balling, and predicts lackluster expectations will cause the stock to soar.CEO Interview, Peter van Stolk, Jones' Soda (JDSA)
Cramer asked Peter van Stolk if Jones' increase should continue now that its exclusive soda contract with Target has expired. While van Stolk commented that Target is a great retailer and that he expects to continue working with them, new opportunities should cause the stock to ramp. One of Jones' major selling points is that it uses pure cane sugar rather than corn syrup."Corn is for cars, and sugar is for sodas," he quipped. Since Jones has had a "monster move," Cramer would wait for it to come down a bit before buying.
Published By SeekingAlpha

Labels: , , , , , ,

Wednesday, January 24, 2007

Bush Aids Ethanol Producers

Ethanol producers and health care service providers are among the potential corporate beneficiaries of policies proposed by President Bush, while domestic automakers and oil companies could get slightly stung.
The winners and losers will be more apparent in the months ahead, as the Democrat-controlled Congress responds to the president's State of the Union speech, though economists said they expect few drastic changes in Washington between now and the 2008 election. In this scenario, the status quo prevails -- a trend Wall Street tends to prefer.
"The business community is quite skeptical that much, if anything, will be produced out of the Congress in the run-up to the 2008 presidential election year," said Allen Sinai, chief global economist at Decision Economics Inc.
Sinai added that Bush's proposals on energy and health care, including a call for a tax deduction of $7,500 for individuals and $15,000 for families regardless of whether they buy their own health insurance or receive medical coverage at work, were not overly ambitious.
But Archer-Daniels-Midland Co., along with US BioEnergy Corp., VeraSun Energy Corp. and other ethanol producers nevertheless stand to benefit from Bush's call to raise consumption targets for ethanol and other alternative fuels to 35 billion gallons by 2017. More than 5 billion gallons were produced in the U.S. in 2006. The long-term technological challenge, experts say, will be finding inexpensive ways to use feedstocks other than corn to meet the higher targets.
Some ethanol stocks were down in pre-market activity Wednesday. Archer-Daniels-Midland dipped 53 cents to $32.10, after adding 81 cents to close at $32.63 on Tuesday, and Pacific Ethanol slid 49 cents, or 2.8 percent, to $17.36 after adding $1.03 to close at $17.85 Tuesday.
Traditional energy companies will have their "antennae up" to monitor the progress of Bush's alternative energy proposals, Sinai said.
Automakers said they were open to the president's goals of increasing fuel economy standards.
The proposal could benefit Japanese automakers such as Toyota Motor Corp. and Honda Motor Co., which have higher fleetwide fuel economy levels than domestic manufacturers. The proposal also includes a system of trading or "banking" credits to meet new standards, which could lead to Detroit's automakers buying fuel credits from Toyota and Honda.
But GM and Ford Motor Co. have pledged to build two million flexible-fuel vehicles by 2010, so they too could benefit by an influx of ethanol and other renewable fuels. GM said it wanted to ensure, however, "that any fuel economy increases are technically achievable and do not compromise safety, performance, or limit consumer choice."
Energy analysts said the call for a sharp escalation in the use of ethanol will have little immediate impact on major oil companies, such as Irving, Texas-based Exxon Mobil Corp. and San Ramon, Calif.-based Chevron Corp., primarily because it'll be used as a partial substitute and not a replacement for gasoline.
In a research note before the speech, Citigroup analyst Doug Leggate called Bush's plan to cut gasoline consumption by 20 percent by 2017 "a huge target, and one where a reality check may be necessary to determine if this is really achievable."
The health care taxation plan is the most appealing to the private sector, analysts said. Specifically, the second part of the provision that would curb health care spending by taxing any expenses over the $7,500 and $15,000 marks, and could drive many Americans to the individual-oriented plans offered by UnitedHealth Group Inc., Wellpoint Inc. and Aetna Inc.
WellPoint and Aetna slid in pre-market trading. WellPoint dipped 88 cents to $76.15 after adding 22 cents to end at $77.03 on Tuesday and Aetna dipped 18 cents to $42 the morning after it closed up 39 cents at $42.18.
The health proposal also would encourage middle- to lower-income individuals to opt for hospital care instead of avoiding visits that formerly would have required out-of-pocket expenses, said Tom Ochsenschlager, vice president of taxation for the American Institute of Certified Public Accountants.
Employers, including automakers, would welcome the plan since benefit costs, not wages, continue to hinder their bottom lines, said Brian Bethune, U.S. economist at Global Insight in Lexington, Mass.
That's good news for hospital operators like Triad Hospitals Inc. and Health Management Associates Inc., and General Motors Corp., the nation's largest private provider of health care.
And the potential health care benefits should outweigh the hit domestic automakers would take if Bush is successful in raising fuel economy standards for passenger cars, economists said.
The president devoted roughly 20 minutes of his speech to the global war on terror, with seven of those minutes spent on Iraq.
The defense industry outlook is dictated primarily by policies in Iraq and Bush's recent call to increase U.S. troops there by 21,500 elicited fierce opposition on Capitol Hill, Nomura's Resler said.
But since Bush's troop announcement on Jan. 10, the stock prices of defense contractors like Hartford, Conn.-based United Technologies, Los Angeles-based Northrop Grumman Corp. and Bethesda, Md.-based Lockheed Martin Corp., are up.
The Defense Department is expected to submit its fiscal year 2008 budget request to Congress for approval next month with initial estimates suggesting it could reach more than $600 billion, which could further bolster defense companies' shares.
AP Business Writers John Porretto in Houston, and Donna Borak, Matthew Perrone and Ken Thomas in Washington, contributed to this report.

Labels: , , , , , , , , , , , , , , ,

Wednesday, January 17, 2007

Hot Stocks to Watch Thursday

Here are 7 stocks for traders for Thursday from TradingMarkets.com:
Apple (NASDAQ:AAPL - News) beat earnings by a long-shot on Wednesday after the bell, announcing $1.14 EPS over an expected $0.78 EPS.
Sovereign Bancorp (NYSE:SOV - News) beat earnings on Wednesday afternoon; SOV reported $0.33 EPS over a consensus of $0.32 EPS. SOV's PowerRating is 6.
Amdocs (NYSE:DOX - News) beat earnings on Wednesday after the close, announcing $0.53 EPS over an expected $0.50 EPS. DOX's PowerRating is 5.
Bank of NY (NYSE:BK - News) reports earnings on Thursday before the bell; watch for $0.55 EPS. BK's PowerRating is 4.
Before opening bell Thursday morning, Continental Airlines (NYSE:CAL - News) will announce earnings, with analysts looking for -$0.15 EPS. CAL's PowerRating is 3.
Analysts are looking for Merrill Lynch (NYSE:MER - News) to report $1.92 EPS on Thursday morning. MER's PowerRating is 5.
When UnitedHealth (NYSE:UNH - News) reports quarterly earnings tomorrow morning, look for $0.85 EPS. UNH's PowerRating is 4.
PowerRatings are courtesy of PowerRatings.net

Labels: , , , , , , ,

Tuesday, January 16, 2007

Jim Cramer's Mad Money Stock Recap, Jan. 15th

Monday's show was a rebroadcast of a program that first aired on December 28, 2006.
Rule #1: Resisting the Business Cycle, United Health Group (NYSE: UNH - News)
Cramer discussed more rules from his books: Jim Cramer's Real Money: Sane Investing in an Insane World, and Jim Cramer's Mad Money: Watch TV, Get Rich. His first rule deals with the business cycle which is largely controlled by the Federal Reserve's raising and cutting interest rates. When rates are reduced, the economy gets stronger, and investors should buy cyclicals such as "the dirty, smokestack stocks that make things like machinery, cars and minerals." When the Fed raises rates, the economy gets weaker, and it is time to get out of cyclical stocks and into companies that produce consumer staples, such as food and drugs. "You can't own cyclical stocks when the economy stinks, and you should stay away from the consumer staples when the economy's stronger," Cramer said, adding that this applies even if a company has strong fundamentals. He recalls his error of holding on to UNH when the economy picked up, and said that the selloff during the boom was a much bigger factor in the stock's decline than UNH's involvement in an options-backdating scandal.
Rule #2: "Analysts are never bullish enough on good stocks, and ... never bearish enough on bad stocks.": Ebay (NASDAQ: EBAY - News), Amazon (NASDAQ: AMZN - News) and Lucent (NYSE: LU - News)
The reason for the second rule is that analysts covering a stock are dealing with an entire sector for which they must find some stocks that are buys, sells and holds. "The Street will almost always treat a sector that's en fuego as being a lot less en fuego than it actually is," he said. Knowing this, investors can more easily spot which sectors are hot but underappreciated. He noted that this happened with oil stocks during certain times in the past few years when the sector was hot. Even the companies that were neglected or had a "sell" rating went up anyway. It can work the other way too, and Cramer thinks that analysts should have stayed bearish on eBay, Amazon and Lucent for a longer period of time.
Rule #3: Don't Be a Snob, Darden (NYSE: DRI - News), Ruth's Chris Steakhouse (NASDAQ: RUTH - News), Morton's (NYSE: MRT - News)
Because analysts inhabit an upper-class bubble, Cramer says they often miss out on companies that make low-end or mid-grade products. While they can more easily relate to stocks such as RUTH and MRT, most analysts missed out on 50% of Darden's big move between January 2005 and March 2006 because they turned their noses up at Red Lobster and the Olive Garden.
Rule #4 : "Whenever a stock is being heavily shorted and heavily hyped at the same time, it's time to sell that stock," NutriSystem (NASDAQ: NTRI - News)
Hype and a large short interest do not mix, but create a battleground where an investors should fear to tread, and Cramer commented, "You don't do something as risky as shorting a stock unless you're a well-educated investor who has done his or her homework on the thing." One can do research on a stock page on Yahoo or Google finance to see the percentage of shares that are shorted, and a large percentage of shorts indicates that there is a problem the bulls don't know about or do not want to face, as was the case with NTRI, which had problems with its distribution model. "So when all the analysts are having their lovefest with the stock, and you have an army of shorts sitting on the sidelines, you should see a red flag," Cramer said.
Rule #5: "Past performance is not indicative of future success."
Cramer warns viewers not to rely on past successes as a model for future investments, since "stocks have no memory and you could lose big." Investors should aim to make money, but not to feel "invincible" if they do and should avoid following the same patterns. Cramer recommended playing by the rules outlined in his books for successful investing.

Labels: , , , , , , , , ,

Monday, January 15, 2007

Weekly Outlook

The background evidence of the week was somewhat mixed and of the type that could always conjure the spin doctors of Wall Street to don the bear goggles. Make no mistake about it though, a decisive shift in investor psychology opted to embrace the bull at large, with the end result fresh multi-year and all-time-highs. For the five day period S&P500 ($SPX) and NASDAQ Composite ($COMPQ) are up 1.49% to 2.82% on sure signs of investor satisfaction.Aggressively lower energy prices certainly helped market bulls this week. It’s not always the case, as the relative weakness and potential earnings concerns over the ‘profit-engine’ of the energy complex (XLE, OIH) need to be ignored or used as the proverbial sacrifice fly, so that other sectors may prosper. That was the case this past week as Black Gold slid precipitously to two year lows. At the same time, the West Texas ETF (USO) fell by -9% to fresh all-time-lows of 43.50 before closing off -6.69% at 44.63. Abnormally warm weather in the northeast, continued bearish build ups of inventories, further not-so-smart institutional monies rotations and trader skepticism over OPEC cuts all played a part in the action. Meanwhile, concern over the ‘price drilling’ being an actual harbinger of a weaker economy dissipated and lost favor with a giddy Wall Street and other data saying something else entirely. After a couple warnings curveballs thrown in the week prior, the official start to the Q4 earnings season was a bullish catalyst for the market. While it’s still too early to determine any type of trend, lowered expectations for Corporate America and a cautious investor mood have been countered by strong results and outlooks from the likes of Alcoa (AA) and Genentech (DNA). While the 22% growth seen in the third-quarter isn’t likely to be matched, bullish reactions to upside surprises thus far do suggest sufficient pessimism coming into the period. Now all Wall Street needs are 450-plus reports from the S&P500, to see if they’ve got it right.One place Wall Street seems certain it has it right is a rotation into large cap technology. An outsized 2.82% gainer and a second straight week of outperformance is a testament to that belief of value found, four plus years into the broader market’s Bull Run. However, as a further testament to a market still composed of stocks and obviously not tolerant of disappointments: sales warnings out of veritable tech names such as Tellabs (TLAB), SAP (SAP) and Advanced Micro (AMD) were punished by investors. While the initial broader market concern / impact was shaken off each time and ultimately favored the “Buy, Buy, Buy!” routine, some canaries outside of the coal / energy mine have been spotted and possibly worth listening too. It also looks like Wall Street is in the mood to embrace strength outside of the corporate kind. Economic data this week contained potentially damaging information for bulls insistent of rate cuts. However, when all was said and done, the market reacted favorably to a stronger economy and one not in need of the Fed easing monetary policy. Friday’s much stronger-than-expected .9% retail sales increase solidified traders shift towards relief over an economy that’s showing more signs of bottoming without further intervention. In fact, some analysts feel the data could point to an upward revision for the Q4 GDP. The bond market is listening as well. Fed funds futures are pricing in almost no chance of a cut before May and treasury yields soared to their best levels in more than two months. The widely followed 10-Year closed at 4.77% and up 13 basis points on the week, but below the key 5% level and a point where another kind of market intervention might come into play.ON TAP THIS WEEKInvestors received an equal dose of high profile surprises and warnings last week, but all told the total count of less than a handful makes for a clean slate as earnings intensify this week. The holiday shortened work-week will have plenty of high-profile names in a myriad of industry groups. Currently, earnings expectations are riding low as Wall Street makes provisions for the end of thirteen quarters of double digit growth from the S&P500. That’s likely to happen, as much of that success was directly linked to the oil patch, which has lost more than a bit of its energy mojo. Financials, also a very heavily weighted group, will likely surprise to the upside as deal making and the capital markets have been benevolent overall. It’s anticipated though that much of what the market does in the coming weeks will be riding heavily on the current rotation into large cap tech and the NASDAQ. Investors won’t want to see further disappointments from that group with so much money now obviously betting on a confirmation of those actions. As mentioned prior, expectations for the Fed cutting rates before May are down to a near zero vote of confidence. The economic data of late has shown both a tightening labor market and enough resilience in the manufactured slowdown to keep interest rates on hold and possibly even nudged up if conditions persist. The current environment is taking place as well, in a market that’s seen hard declines in physical prices of underlying commodities. That means that should those prices firm, an additional force could also be at work, as to keep a rate cut out of the equation for 2007. The week is full of fresh data on both the inflation and growth fronts, so economic watchdogs should make sure to keep note of what’s on tap by looking at the schedule below. What does a rate cut or none offered actually mean to investors? The underlying theme that a reduction is good for the market will always have a home on Wall Street. However, the current popular vote—as evidenced by higher stock prices—is geared towards wanting an economic turnaround despite some concerns over higher price pressures. Until yields move to levels that are deemed attractive enough to pull the rug from under equities, Wall Street can apparently have its cake and eat it too.
TuesdayEconomic: NY Empire Index (20)Earnings: Ameritrade (AMTD), Forest Labs (FRX), US Banc (USB), Wells Fargo (WFC), Intel (